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Abstract
Background
Human African Trypanosomiasis (HAT) is a neglected disease targeted for elimination as a
public health problem by 2020. Elimination requires a better understanding of the epidemiol-
ogy and clinical evolution of HAT. In addition to the classical clinical evolution of HAT,
asymptomatic carriers and spontaneous cure have been reported in West Africa. A genetic
component to human susceptibility to HAT has been suggested to explain these newly
observed responses to infection. In order to test for genetic associations with infection
response, genetic polymorphism in 17 genes were tested (APOL1, IL1B, IL4, IL4R, IL6, IL8,
IL12B, IL12RB1, IL10, TNFA, INFG, MIF, HLA-G, HLA-A, HP, HPR and CFH).
Methodology
A case-control study was performed on 180 blood samples collected from 56 cases and 124
controls from Cameroon. DNA was extracted from blood samples. After quality control, 25
samples (24 controls and 1 case) were eliminated. The genotyping undertaken on 155
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individuals including 55 cases and 100 controls were investigated at 96 loci (88 SNPs and 8
indels) located on 17 genes. Associations between these loci and HAT were estimated via a
case-control association test.
Results
Analyses of 64 SNPs and 4 indels out of 96 identified in the selected genes reveal that the
minor allele (T) of rs8062041 in haptoglobin (HP) appeared to be protective against HAT
(p = 0.0002395, OR 0.359 (CI95 [0.204–0.6319])); indicating higher frequency in cases com-
pared to controls. This minor allele with adjusted p value of 0.0163 is associated with a
lower risk (protective effect) of developing sleeping sickness.
Conclusion
The haptoglobin related protein HPR and HP are tightly linked and both are duplicated in
some people and may lead to higher activity. This increased production could be responsi-
ble of the protection associated with rs8062041 even though this SNP is within HP.
Author summary
Human African trypanosomiasis (HAT) or sleeping sickness is a neglected tropical disease
targeted for elimination by 2020. This elimination requires a better understanding of the
epidemiology and clinical evolution of this disease. Beside the classical clinical evolution,
asymptomatic carriers, seropositive and spontaneous cure of infected persons have been
reported in West Africa. Arguments in favor of human genetic susceptibility to HAT have
been raised to explain this variability in clinical presentation. This study investigated the
genetic polymorphism of 17 genes between controls and sleeping sickness patients in
Southern Cameroon in order to improve our knowledge of human susceptibility to try-
panosome infections. We identified single nucleotide polymorphisms and indels in 17
selected genes involved in immune responses and carried out a case-control candidate
gene association study and demonstrated differences between variants associated with the
disease. From these genes, only haptoglobin (HP) at the SNP rs8062041 was found to have
polymorphisms which were strongly associated with trypanosomiasis. The minor allele
(T) at this SNP position appeared to be protective against HAT (p = 0.0002395, OR 0.359
(CI95 [0.204–0.6319])) reducing the risk of developing disease approximately threefold.
The haptoglobin related protein (HPR) is adjacent to HP and is a component of the Trypa-
nolytic factor that kills trypanosomes. The HP and HPR locus is duplicated in some peo-
ple. The rs8062041 variant may be associated with this duplication and it is possible that
increased production of HPR is the cause of the protection associated with rs8062041. The
results reported here will contribute to the knowledge of the role of human genetics in dis-
ease progression, and thus lead to the identification of novel biomarkers which could
involve development of new diagnostics, treatments and intervention strategies.
Introduction
Human African Trypanosomiasis (HAT) or sleeping sickness is a lethal neglected tropical dis-
ease responsible for severe morbidity and economic losses in areas where it occurs [1]. HAT is
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caused by subspecies of Trypanosoma that are transmitted to humans through the bites of
hematophagous flies of the genus Glossina, commonly known as tsetse flies. HAT exists in two
forms: the acute form due to Trypanosoma brucei rhodesiense, which occurs in East Africa, and
the chronic form due to T. b. gambiense, which is found in West and Central Africa. More
than 98% of the currently reported cases belong to the chronic form. About 65 million people
are estimated to be at risk of HAT and the current number of HAT cases is below 20,000 pa
[2]. Control efforts undertaken during the last decades have reduced considerably the number
of cases and 3,796 new cases were reported to WHO in 2014 [2]. With the success of these con-
trol efforts, HAT has been included in the WHO roadmap of neglected tropical diseases which
are targeted for elimination as a public health problem by 2020. For effective control, it is
important to gain a better understanding of the clinical evolution of the disease. Previously,
HAT was classically considered to be fatal if untreated. During the last decades, a range of clin-
ical presentations of T. b. gambiense HAT have been reported including asymptomatic carriers
and spontaneous cure without treatment [3]. One hypothesis for the diversity of clinical out-
comes that occur during infections due to T. b. gambiense is that it is due to human genetic
variability. Previous investigations on genes such as HLA-A, HP, CFH, IL1B, IL12B, IL12RB1,
IL4R and HPR [4, 5, 6, 7, 8, 9, 10, 11, 12] revealed associations between the polymorphisms in
some of these genes with infectious diseases including HIV, viral hepatitis, malaria and tuber-
culosis. In HAT, polymorphisms in sequence or expression of genes involved in immune
response such as APOL1, IL4, IL6, IL10, IL8, TNFA, HLA-G, MIF, HPR and INFG have been
investigated for their association with the outcome of T. b. gambiense infections [13, 14, 15, 16,
17, 18, 19, 20, 21, 1]. These investigations found associations between some polymorphisms in
genes and the risk of developing HAT. For instance, Courtin et al. [14–16] have shown that
polymorphisms in IL6, IL10 and HLA-G were associated with a protective effect against HAT.
In addition, a protective effect has been observed in vitro and in vivo of the G2 allele of APOL1
against infections due to T. b. rhodesiense [22]. In Guinea, the G1 allele of APOL1 was found to
be associated with protection of asymptomatic individuals against development of active dis-
ease [22]. Despite these observations, the relationship between genetic polymorphisms and
susceptibility to HAT is still not well understood and further investigations on populations of
more HAT foci are required.
To improve our knowledge of the genetic determinants that could play important roles dur-
ing infections due to T. b. gambiense, seventeen genes were selected in this study and their
polymorphisms were investigated within populations of three sleeping sickness foci of the for-
est region of Cameroon.
Study area and study population
The study was conducted in three active sleeping sickness foci of the forest region of Southern
Cameroon (Fig 1). The Cameroonian population is made up of more than 240 ethnic groups
that can be grouped into Bantu (e.g.: Beti, Bassa, Bakundu, Maka, Douala, Pygmie), Semi
Bantu (e.g.: Bamileke, Gbaya, Bamoun, Tika) and Sudano-Sao (e.g.: Fulbe, Mafa, Toupouri,
Shoa-Arabs, Moundang, Massa, Mousgoum). The composition varies considerably between
HAT foci and even within the same HAT focus. The three HAT foci where this study was
undertaken were Bipindi and Campo in the Southern region and Fontem in the South-west
region of Cameroon.
The Campo focus (2˚82’00"N, 9˚85’20"E) is located in the tropical forest and extends from
the Atlantic coast along the Ntem river which delimits the Cameroon–Equatorial Guinea bor-
der. It is a hypo-endemic focus with no history of epidemic outbreaks [23] and a cumulative
number of 98 cases were detected between 1998 and 2013. The main source of livelihood for
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the inhabitants of the Campo focus is agriculture, fishing and hunting. It is a cosmopolitan
area with several ethnic groups including mainly the Iyassa, Kwasse, Maabi, Mvae and
Ngoumba, most of whom are Bantu speaking. Other minor ethnic groups are semi Bantus and
Sao-Sudanese and can be found at Campo for administrative and socioeconomic purposes.
The Bipindi HAT focus (3˚82’00"N, 10˚82’20"E) is located at about 75 km from the Atlantic
coast in the South of Cameroon. It is an old HAT focus that has been known since 1920. Dur-
ing the last two decades, the Bipindi focus was among the most active HAT foci of Cameroon
with around 83 HAT cases diagnosed from 1999 to 2011 [24]. About 95% of the inhabitants of
the Bipindi HAT focus are Bantu speaking and belong to ethnic groups such as Ngoumba, Nti,
Fan and Pygmies. The remaining 5% of inhabitants (semi Bantus and Sao-Sudanese) are there
for administrative and socioeconomic purposes. The main livelihood for people in this focus is
hunting, farming and seasonal harvesting of fruits.
The Fontem focus (5˚40’00”N, 9˚55’00”E) is located in the South-West Region of Camer-
oon where HAT has been known to occur since 1949 [25]. The Fontem focus was previously
among the most active HAT foci of Cameroon [26], but in recent decades, it has become
hypoendemic with about 8 patients detected among 16,000 persons examined between 1998
and 2007 [27]. In this focus, the Mundani, Bamoua and Bangwa are the major ethnics groups.
Other minor ethnic groups such as Banyangue and Bamileke are also found.
Materials and methods
Sample collection
The blood samples were collected during medical surveys performed jointly with the national
sleeping sickness control program of Cameroon. The sampling was done at Campo in 2014
and for Bipindi and Fontem, in 2015. During these surveys, all inhabitants were screened with
CATT test [28] on whole blood. All inhabitants with positive CATT test were subjected to
Fig 1. HAT foci where samples were collected.
https://doi.org/10.1371/journal.pntd.0005979.g001
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CATT dilution on plasma and each inhabitant positive on a CATT dilution1/8 was sub-
jected to parasitological examination (capillary tube centrifugation (CTC) [29] and minianion
exchange centrifugation technique (mAECT)) [30]. For all inhabitants with CATT dilution
1/8 and negative for all parasitological tests, 90μl of plasma were spotted on a Whatman
paper disc (divided in four equal parts with each bearing a spot of 30μl) that was sent to CIR-
DES in Burkina Faso for the trypanolysis test [31]. Beside the CTC and mAECT, lymph node
aspiration followed by a microscopic examination was performed to search for trypanosomes
in all individuals showing enlarged lymph nodes. A new HAT case was defined as an inhabi-
tant in whom trypanosomes were seen by at least one parasitological method. Beside these new
HAT cases, old HAT cases were also resampled. Old HAT cases were residents in whom try-
panosomes had been previously seen on at least one parasitological test after passive or active
case detection. Old HAT cases were only included in this study if the information regarding
the clinical status, the CATT test and all parasitological tests were available in hospital records.
A control was considered as any individual negative for the CATT test, all parasitological tests
including CTC, mAECT and lymph node examination and when possible the trypanolysis
test.
With these sampling criteria, 5ml of peripheral venous blood samples were collected from
cases and controls into EDTA coated tubes. In the field, the tubes were mixed gently and
stored at 4˚C in an electric cooler before being transported to the laboratory.
Ethics statement
The protocol of this study was approved by the Ethical Committee of the Ministry of Public
Health of Cameroon reference number N˚2013/11/364/L/CNERSH/SP of 21 November 2013.
The local administrative and traditional authorities of each HAT focus were also informed and
gave their approval. Subsequently, the review board (LAMAS) of Laboratory of Microbiology
and Anti-microbial substances of the Department of Biochemistry of the Faculty of Science of
the University of Dschang gave their approval. All adult subjects provided informed consent,
and a parent or guardian of any child participant below 18 years old provided informed con-
sent on their behalf. Each informed consent was written because all individuals enrolled in this
study gave their approval by signing an informed consent form and a Certificate of Confidenti-
ality. During analyzes, data of each subject were anonymized.
DNA extraction
Blood samples were centrifuged at 5000rpm for 3 minutes and the buffy coat was collected.
Genomic DNA was extracted from the Buffy-coat with the QIAamp DNA Blood Midi/Maxi
kit (Qiagen) according to the manufacturer’s instructions. The DNA was eluted with 200μl of
elution buffer and stored at -20˚C until use.
Power calculation
Power calculations were undertaken using the genetics analysis package gap in r [32]
Selection of candidate genes
The choices of candidate genes were based on previous observations. The cytokines IL4, IL6,
IL10, IL8, INFG, TNFA, HP, HPR and MHC gene HLA-G were selected because they have been
previously associated with HAT [14–16, 20, 33, 34, 35, 36, 37]. In addition, two genes for fac-
tors involved in the lysis of trypanosomes, APOL1 and haptoglobin-related protein (HPR)
were also included [17, 18, 19]. Five further genes that had previously been reported to play an
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important role in the susceptibility to other infectious diseases were selected: Human Leuko-
cytes Antigen A (HLA-A) [38, 4, 39], IL1B [10], Complement factor H (CFH) [6, 10], IL12B
and IL12RB1 [5, 11] and Macrophage migration inhibitory factor (MIF) [40, 41, 42] genes
were also included.
SNPs and INDELs selection
Most SNPs and indels for testing were selected after a Linkage scan (r = 0.5) and quality con-
trol with Plink version 1.9 [43] using whole genome sequencing data. These data were
obtained from a merged dataset between the African populations data from the 1000 Genomes
Project combined with low fold coverage (8-10x) whole genome shotgun data generated from
230 residents living in regions (DRC, Guinea Conakry, Ivory Coast and Uganda, European
Genome Archive A accession number) where trypanosomiasis is endemic [44]. The 88 SNPs
and 8 indels loci were selected by two strategies: 1) by linkage scan of SNPs and indels (r2 <
0.5) across the gene; 2) by selection of SNPs and indels with published associations with HAT.
Linked SNPs were identified for IL6, IL4, IL8, IFNG and HLA-G genes. For APOL1, HPR, HP,
HLA-A, IL1B, IL12B, IL12RB1, IL4R, CFH, IL10, MIF and TNFA genes, individual published
SNPs and indels were identified and selected based on literature searches.
Genotyping
Samples which had low DNA concentration or did not satisfy the quality control criteria were
excluded prior to genotyping. Genotyping was performed by two commercial service provid-
ers: 1) “Plateforme Genome Transcriptome” at INRA of Bordeaux in France; 2) LGC Geno-
mics Hoddesden, UK with approximately 1μg of genomic DNA per sample.
At INRA, genotyping was carried out with a Multiplex design (two sets of 40 SNPs or
indels) using Assay Design Suite v2.0 (Agena Biosciences). For each SNP and indel, the geno-
typing was done with the iPLEX Gold genotyping kit (Agena Biosciences) for the Mass-Array
iPLEX genotyping assay according to the manufacturer’s instructions. Products were detected
on a Mass-Array mass spectrophotometer and data were obtained in real time with Mass-
Array RT software (Agena Biosciences). SNP clustering and validation was carried out with
Typer 4.0 software (Agena Biosciences). A summary of the candidate genes, and SNPs and
indels is shown in the supplementary data S1 Table. Some SNPs and indels that failed genotyp-
ing at INRA and some additional SNPs and indels were genotyped at LGC Genomics, Hoddes-
den, UK where SNPs and indels were genotyped using the PCR based KASP assay [45].
Analysis
This was a case-control study where no familial controls were collected during sampling. The
raw genotypic data were converted to PLINK format and quality control (QC) procedures
implemented using the PLINK v1.9 package [43]. The Spearman Chi-square test was used to
compare frequencies of observed and expected genotypes under Hardy–Weinberg equilibrium
(HWE) and LD using R/Rstudio version 3.3.2 (2016-10-31)—‘Sincere Pumpkin Patch’ and
Plink [43]. After quality control and filtering, poorly performing SNP loci with missing geno-
types (10) and samples with missing loci (4) were removed. In addition, all loci with a
MAF below 1% or a HWE P value < 1 × 10−4 were removed. SNP in linkage with adjacent
SNP (r> 0.5) were also pruned. These filters are as described by Anderson et al. [46] to mini-
mize the influence of genotype-calling artifacts in a candidate gene study. The association
between individual SNPs and indels within genes and HAT were tested using the Fisher exact
test with Plink v1.9 software. Results were adjusted for multiple testing by Bonferroni correc-
tion. To show significant association during multiple tests, a single marker (SNP) must show,
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after Bonferroni correction, an alpha value (obtained P value before correction/number of
SNPs analyzed) below 0.000746 (0.05/68). The Bonferroni correction assumes that each of the
statistical tests is independent; however, this is not always true due to the possibility of linkage
disequilibrium among the SNPs. In instances where the assumption is not true, the correction
is often too strict, leading potentially to false negatives. A less stringent correction for multiple
testing was also employed. The Benjamini-Hochberg false discovery rate (FDR) estimates the
proportion of significant results (P< 0.05) when the Bonferroni correction considers them as
false positives [47, 48]. FST is a measure of differences between populations. The analysis of FST
was run to check for significant allele frequency difference between the cases and controls
while Principal Component Analysis (PCA) was used to check for population stratification
that might confound the analysis using Plink [43].
Accession number
European Genome Archive A accession number: EGAS00001002602.
Results
Study design and population
This study was one of six studies of populations of HAT endemic areas in Cameroon, Cote
d’Ivoire, Guinea, DRC, Malawi and Uganda. The studies were designed to have 80% power to
detect odds ratios (OR) >2 for loci with disease allele frequencies of 0.15–0.65 and 100 cases
and 100 controls with the 96 loci genotyped.
Overall, 216 individuals were included in this study: 56 (25.93%) HAT patients and 160
(74.07%) controls. The 216 individuals belonged to 22 different ethnic groups. The mean age
(range) of HAT cases was 44.94 (15–82) years, while that of controls was 37.08 (9–86). The
overall sex ratio (male/female) was 1.02 (109/107), with HAT cases being 0.75 (24/32) and con-
trols 1.12 (84/75). Given that only 56 cases were available from our study area, the power of
this study was reduced and it had 80% power to detect an OR>3 with disease allele frequen-
cies of 0.1–0.45 with the 96 loci genotyped.
One hundred and eighty (56 HAT cases and 124 controls) of the 216 samples were sent for
genotyping. After DNA quantification and quality control on each of these 180 samples, 25
were excluded from genotyping. 155 samples were genotyped: 55 (34.48%) HAT cases and 100
(64.52%) controls.
Genes and SNPs selected and genotyped
96 loci containing 88 SNPs and 8 indels were tested from 17 candidate genes. The number of
SNPs and indels analyzed varied considerably (from 1 to 18) between genes (Table 1). The
highest number of 18 SNPs and indels was observed for HLA-G and the lowest number of one
SNP for IL10, IL1B and CFH. However, it is important to point out that for APOL1 (three
SNPs), CFH, TNFA, HLA-A and IL10, the SNPs considered here are only those that have been
already reported in the literature. Of the 88 SNPs and 8 indels used in this study, 24 SNPs and
4 indels (with 8 removed for MAF1%, 7 for missing loci10%, 5 with HWE P-values <1 x
10−4 and 8 for linkage at r 0.5) of them were excluded during quality control which excluded
one gene (HLA-A) completely. Four samples were also excluded during quality control due to
missing individual data4%. For subsequent analyses, 69.29% of loci including 64 SNPs and 4
indels from 16 genes and 151 (97.42%) samples will be considered for association analysis
(Table 1).
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The principal components (S1 Fig: supplementary data) and FST values (S2 Table: supple-
mentary data) analysis showed that cases and controls were evenly dispersed (homogenous
and samples did not cluster by phenotype); indicating that the population and subpopulation
structure is not the driving force in our observations.
Genotyping results
Alleles for the sixteen genes and 64 SNPs and 4 indels analyzed were all in Hardy–Weinberg
equilibrium (S2 and S3 Tables: supplementary data); suggesting random genetic exchange
within the studied populations. The MAF varied considerably across SNP and indel (S2 Table:
supplementary data) with the lowest MAF at rs11575934 in IL12RB1 (MAF = 0.0067) and the
highest value at rs371194629 in HLA-G (MAF = 0.5).
The minor allele (T) of rs8062041 in HP appeared to be protective against HAT
(p = 0.00024). An odds ratio (OR) of 0.359 (CI95 [0.20–0.63]) indicated low frequencies in
cases compared to controls. This SNP is located in a copy number variation (CNV) essv41754
that spans both HP and HPR (Fig 2).
In addition, the minor alleles of IL4 and HLA-G also appeared protective (IL4: C rs2070874,
uncorrected p = 0.047: and HLA-G: G rs1233330, uncorrected p = 0.011). The OR of 0.62 (CI95
[0.38–1.01]) for rs2070874-IL4 C and 0.2754 (CI95 [0.093–0.81]) for rs1233330 HLA-G also
indicated low frequencies of the major allele in cases compared to controls. However, for
HLA-G, the minor allele (A) of SNP rs17875389 had a higher frequency in cases than controls
(p = 0.042). The OR of 2.29 (CI95 [0.97–5.39]) suggests that the A allele may increase the risk
of developing HAT.
Of the 64 SNPs and 4 indels considered here, only four (SNP) of them belonging to three
genes were associated with the development of HAT before Bonferroni correction (Table 2).
After Bonferroni correction only one SNP (rs8062041 T/C) in HP was associated with HAT.
The odds ratio of 0.359 suggests that the minor allele has a protective effect within the
Table 1. Number of SNPs and indels identified and selected for each gene.
Chromosome Gene Number of SNPs and indels identified and selected Number SNPs and indels retained*
1 IL10 1 1
1 CFH 1 1
2 IL1B 1 1
4 IL8 6 5
5 IL4 16* 13*
5 IL12B 2 2
6 HLAG 18* 9*
6 TNFA 3* 2
6 HLAA 3 -
7 IL6 12 10
12 IFNG 10 10
16 HP 2 2
16 HPR 3 2
16 IL4R 1 1
19 IL12RB1 2 1
22 MIF 9 3
22 APOL1 6* 5*
* Genes with indels loci genotyped and retained after QC for analysis
https://doi.org/10.1371/journal.pntd.0005979.t001
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Cameroonian population with 95.3% (FDR) chance of this locus being associated with HAT
(Table 2).
For the three remaining SNPs where the association was not significant after Bonferroni
correction, our results show that the allele frequencies in cases and controls were not the same
(Table 2) and that there is some possibility of an association with disease. FDR_BH is the prob-
ability of falsely rejecting the null hypothesis that allele frequencies are the same in cases and
controls. rs1233330 and rs17875389 in HLA-G had FDR_BH values of 0.36 and 0.67 respec-
tively; suggesting that there are 64% and 33% probabilities of an association between SNPs at
these loci with HAT. For rs2070874 in IL4, the FDR_BH value of 0.722 suggests 27.8% chance
of an association with HAT.
For the other genes (APOL1, IL4, IL6, IL10, IL8, TNFA and INFG) involved in immune
response that have been previously investigated in HAT, our results revealed no statistical
association with the disease within the Cameroonian population (S1 Table). No association
was also observed with SNP and indel of APOL1 and all SNPs of HLA-A, IL1B, IL12B, CFH,
IL12RB1, IL4R and MIF previously associated with the susceptibility to other infectious dis-
eases (S2 Table: supplementary data).
Fig 2. Locations of SNPs genotyped on HP/HPR region.
https://doi.org/10.1371/journal.pntd.0005979.g002
Table 2. Loci with significant associations with HAT.
CHR Gene SNP BP Allele F_A F_U Nominal P OR Hwe-P MAF BONF FDR_ BH
6 HLA-G rs1233330 29799103 A* 0.04167 0.1364 0.011 0.275 0.0157 0.1054 0.67 0.3632
G**
6 rs17875389 29794484 G* 0.1176 0.055 0.042 2.291 1 0.07616 1 0.6708
A**
16 HP rs8062041 72088964 T* 0.2959 0.4948 0.0002 0.359 1 0.4338 0.016 0.01629
C**
5 IL4 rs2070874 132009710 T* 0.3529 0.47 0.0071 0.615 0.5463 0.4305 1 0.722
C**
SNP: single nucleotide polymorphism, BP base-pair location
* minor allele
** major allele; F_A & F_U frequency of the minor allele in cases and controls respectively; Nominal P unadjusted asymptotic probability value; OR odds
ratio; HWE-P Hardy-Weinberg equilibrium p value for unaffected individuals; BONF Bonferroni adjusted asymptotic p value, FDR_BH = False Discovery
Rate Benjamin-Hochberg, MAF Minor allele frequency, CHR: Chromosome.
https://doi.org/10.1371/journal.pntd.0005979.t002
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Discussion
In this study we obtain good quality genotype data for a total of 64 SNPs and 4 indels in 16
genes to investigate associations with trypanosomiasis. Of these genes selected on the basis of
their association with HAT or other infectious diseases, most were not statistically associated
with HAT in Southern Cameroon.
The most important result of this study is the observation that the T allele of SNP
rs8062041-HP with a p-value of 0.00024 (Bonferonni corrected p = 0.015) and an OR of 0.36 is
associated with a lower risk (protective effect) of developing sleeping sickness. This SNP lies
within intron 1–2 of HP of the CNV essv41754 that spans both HP and HPR transcripts (Fig
2). Although the biological significance of this CNV is not well understood, it is important to
point out that HP and HPR have some biological similarities. Haptoglobin is involved in the
scavenging of haem from lysed red blood cells. Trypanosome infections induce extensive lysis
of red cells releasing haem which is scavenged by HP. In mice, the expression of the haptoglo-
bin receptor (Cd163) on macrophages declines dramatically after infection with T. congolense
[49] and is the earliest indicator of infection. HPR also binds haem but is not cleared from cir-
culation after haemolysis. However, HPR is of particular interest because it plays a prominent
role in the innate resistance of humans to most Trypanosoma species [50]. This innate resis-
tance is linked to trypanosome lytic factors 1 and 2 (TLF1, TLF2) which are bound to a minor
subclass of high-density lipoprotein (HDL) [51]. Both factors harbor APOL1, which is the try-
panolytic component [52], and HPR which facilitates the uptake of APOL1 via trypanosome
haptoglobin–hemoglobin receptors (HpHbR).
Interestingly, rs8062041-HP (T/C) is located on chromosome 16 (16q22.2) in the CNV
essv41754 that spans both HP and HPR (Fig 2). Such genomic structural variants involving
HP/HPR duplication have been reported with higher frequency in people of African descent
[53, 7]. For instance, HP and HPR have been reported in 29 independent studies listed in the
Database of Genome Variants [54]. T. b. gambiense protects itself against killing by APOL1 by
reducing the abundance and affinity of the receptor for HPR [55]. If rs8062041, located in the
CNV essv41754 spanning HP and HPR is correlated with CNV genotype, then an increase in
HPR expression could drive increased uptake of APOL1 and parasite killing. As in other dis-
eases such as heart disease, cancer, malaria and Crohn’s disease, polymorphism in HP could
also have direct biological significance in HAT. Polymorphism in the haptoglobin gene may
be associated with reduced cholesterol levels in the blood [56] and since cholesterol is specifi-
cally taken up by trypanosomes as a nutrient, any reduction in cholesterol might restrict para-
site growth rate. There are numerous variants of HP, some of which may have arisen from
gene conversion from HPR exons [56]. Single SNP tag these variants poorly (max r2 = 0.44),
however SNP haplotypes can tag these variants efficiently (max r2 = 0.92) and are more
strongly correlated with cholesterol levels than individual SNP [56]. High density genotyping
of the HP/HPR locus will be required to understand the role of this locus in the response to
trypanosome infection. Although rs8062041 is within HP, the known involvement of HPR in
APOL1 mediated killing means that increased expression of HPR is another mechanism by
which this SNP could be associated with the observed difference in likelihood of developing
HAT. Our results showing an association between HAT and one SNP located within a CNV
spanning HP and HPR duplication are not in line with results of Hardwick et al. [18] who
observed no association with the HPR duplication allele and HAT in DRC. The difference
between these results could be linked to the position of SNP within HP, the genetic diversity
between the studied populations as well as the sampling methods. In our study, a case control
approach was used while Hardwick et al. [18] used family-based sampling. Bresalier et al. [57]
reported an association between polymorphisms at some HPR loci with an increasing risk of
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developing colon cancer. Similar associations were outlined by Tabak et al. [58] for HPR/
APOL1 loci variations in hepatoma and leukemia. There are also examples of CNV mediating
different susceptibilities to infectious diseases [59, 60].
Of the twelve SNPs of IL6 identified and investigated in our study, none of them revealed
an association with HAT. However, with similar investigation on the same gene, Courtin et al.
[15] showed a T allele of the IL6 (4339) SNP rs2069849 which was significantly (Bonferroni
corrected p = 0.04) associated with a decreased risk of developing HAT in the DRC. This SNP
was not genotyped in this study because it could not be multiplexed with the others in the
panel. The discrepancy between our results and those of Courtin et al. [15] could be due to
insufficient linkage between our marker SNP and rs2069849 and or genetic differences
between the DRC and Cameroon populations. The study designs also differed; we used a case
control approach while Courtin et al. [15] used a family-based design and our study was
smaller.
It has been suggested that the G1 and G2 alleles of APOL1 which increase the risk of devel-
oping kidney disease are under selection because they confer resistance to HAT [17]. Our
observations on APOL1 are consistent with Cooper et al. [22] who found no association with
APOL1 G1 and G2 in a comparison of cases and active T.b.gambiense HAT.
Concerning HLA-G, our results showed a protective effect of developing HAT for the loci
rs17875389 G/A (p = 0.0416 and OR of 2.291) and an increased risk effect for rs1233330 A/G
(p = 0.01105 and OR of 0.2754). These results support those of Courtin et al. [14] who reported
similar results for different SNPs of the same genes in the DRC.
The association with IL4 rs2070874 T/C (p = 0.00712 and OR of 0.6151) is the first time this
has been observed in HAT although associations with IL4 have been observed in South Ameri-
can trypanosomiasis [61, 62]. The presence of IL4 in extravascular tissues promotes alternative
activation of macrophages into M2 cells and inhibits classical activation of macrophages into
M1 cells. This increase in repair macrophages (M2) is coupled with secretion of IL10 and
TGFB that result in a diminution of pathological inflammation [63].
The results discussed above for IL4 and HLA-G are based on FDR_BH values should be
used with caution because no association was found after correction for multiple testing.
However, we were only able to collect a relatively small number of cases (56) for this study,
despite conducting large-scale field surveys. Whilst our power calculations indicated that
effects of the sizes observed could be detected with our relatively small number of samples,
larger cohorts of well phenotyped cases and controls may be required to confirm these
observations. Therefore, although the present data is only suggestive of an association, the
finding of suggestive associations in multiple populations increases the probability that
these are genuine associations with disease [64]. This challenge is precisely what the Trypa-
noGEN network, a consortium of partners in eight African and three European countries
seeks to address. The network has collected from seven regions in six countries (Cameroon,
Cote d’Ivoire, DRC, Malawi, Uganda, and Zambia) a total of 3301 samples from cases and
controls to include in a genome-wide-association study [44] which will be used to test the
hypotheses generated here.
Conclusion
The results of this study reveal an absence of association between HAT and several SNPs iden-
tified in genes previously associated with HAT within inhabitants of sleeping sickness foci of
other African countries. An association between one SNP in HP and the susceptibility to HAT
was revealed in inhabitants of sleeping sickness foci of Cameroon. Located within a CNV that
spans both HP and HPR and given the known involvement of HPR in response to HAT, the
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association of rs8062041 with a CNV is the most plausible mechanism by which this SNP
could be associated with protection against HAT. Our results reveal also that the association
between host genetic determinants or gene polymorphisms and the susceptibility to T. b. gam-
biense infections may vary according to studied populations.
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